Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

NCT00458536 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Renal Cancer

Interventions

BIOLOGICAL: Dendritic Cell Tumor Fusion Vaccine
DRUG: Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]